日本ケミファの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/04/27 | 5,170 | 5,300 | 5,170 | 5,240 | +10 | +0.2% | 3,500 |
| 2017/04/26 | 5,150 | 5,290 | 5,150 | 5,230 | -10 | -0.2% | 2,600 |
| 2017/04/25 | 5,010 | 5,320 | 5,010 | 5,240 | +130 | +2.5% | 2,800 |
| 2017/04/24 | 5,140 | 5,140 | 4,970 | 5,110 | +90 | +1.8% | 1,600 |
| 2017/04/21 | 4,965 | 5,080 | 4,960 | 5,020 | +60 | +1.2% | 1,200 |
| 2017/04/20 | 4,945 | 4,980 | 4,945 | 4,960 | +20 | +0.4% | 1,900 |
| 2017/04/19 | 4,950 | 5,070 | 4,940 | 4,940 | -90 | -1.8% | 3,500 |
| 2017/04/18 | 5,060 | 5,060 | 5,010 | 5,030 | -20 | -0.4% | 1,100 |
| 2017/04/17 | 5,020 | 5,080 | 5,020 | 5,050 | +30 | +0.6% | 1,000 |
| 2017/04/14 | 5,020 | 5,070 | 5,020 | 5,020 | ±0 | ±0% | 1,800 |
| 2017/04/13 | 5,030 | 5,030 | 5,020 | 5,020 | -10 | -0.2% | 1,100 |
| 2017/04/12 | 5,020 | 5,030 | 5,020 | 5,030 | -10 | -0.2% | 900 |
| 2017/04/11 | 5,020 | 5,070 | 5,020 | 5,040 | -40 | -0.8% | 1,500 |
| 2017/04/10 | 5,060 | 5,110 | 5,030 | 5,080 | +40 | +0.8% | 1,300 |
| 2017/04/07 | 5,020 | 5,110 | 5,020 | 5,040 | +20 | +0.4% | 1,200 |
| 2017/04/06 | 5,010 | 5,160 | 5,010 | 5,020 | -20 | -0.4% | 3,800 |
| 2017/04/05 | 5,170 | 5,170 | 5,030 | 5,040 | -150 | -2.9% | 3,500 |
| 2017/04/04 | 5,240 | 5,240 | 5,150 | 5,190 | -20 | -0.4% | 1,600 |
| 2017/04/03 | 5,300 | 5,300 | 5,210 | 5,210 | -80 | -1.5% | 2,900 |
| 2017/03/31 | 5,310 | 5,340 | 5,280 | 5,290 | -60 | -1.1% | 3,500 |
| 2017/03/30 | 5,320 | 5,410 | 5,320 | 5,350 | -40 | -0.7% | 1,700 |
| 2017/03/29 | 5,440 | 5,460 | 5,340 | 5,390 | +10 | +0.2% | 1,100 |
| 2017/03/28 | 5,370 | 5,380 | 5,310 | 5,380 | +90 | +1.7% | 2,800 |
| 2017/03/27 | 5,340 | 5,350 | 5,270 | 5,290 | -50 | -0.9% | 3,900 |
| 2017/03/24 | 5,390 | 5,400 | 5,300 | 5,340 | -140 | -2.6% | 4,800 |
| 2017/03/23 | 5,500 | 5,520 | 5,480 | 5,480 | -20 | -0.4% | 4,000 |
| 2017/03/22 | 5,500 | 5,530 | 5,500 | 5,500 | -10 | -0.2% | 3,800 |
| 2017/03/21 | 5,500 | 5,540 | 5,500 | 5,510 | -40 | -0.7% | 3,000 |
| 2017/03/17 | 5,510 | 5,550 | 5,500 | 5,550 | +20 | +0.4% | 4,000 |
| 2017/03/16 | 5,500 | 5,530 | 5,500 | 5,530 | -10 | -0.2% | 2,800 |
| 2017/03/15 | 5,510 | 5,540 | 5,510 | 5,540 | +10 | +0.2% | 1,200 |
| 2017/03/14 | 5,520 | 5,530 | 5,510 | 5,530 | ±0 | ±0% | 1,100 |
| 2017/03/13 | 5,560 | 5,560 | 5,530 | 5,530 | -30 | -0.5% | 1,600 |
| 2017/03/10 | 5,600 | 5,600 | 5,550 | 5,560 | +30 | +0.5% | 4,200 |
| 2017/03/09 | 5,500 | 5,550 | 5,500 | 5,530 | +30 | +0.5% | 1,500 |
| 2017/03/08 | 5,510 | 5,510 | 5,500 | 5,500 | -20 | -0.4% | 1,300 |
| 2017/03/07 | 5,510 | 5,520 | 5,510 | 5,520 | ±0 | ±0% | 900 |
| 2017/03/06 | 5,520 | 5,530 | 5,500 | 5,520 | -20 | -0.4% | 1,800 |
| 2017/03/03 | 5,570 | 5,570 | 5,520 | 5,540 | -20 | -0.4% | 1,000 |
| 2017/03/02 | 5,570 | 5,570 | 5,530 | 5,560 | +10 | +0.2% | 1,000 |
| 2017/03/01 | 5,540 | 5,580 | 5,540 | 5,550 | ±0 | ±0% | 900 |
| 2017/02/28 | 5,550 | 5,560 | 5,540 | 5,550 | +10 | +0.2% | 1,600 |
| 2017/02/27 | 5,500 | 5,540 | 5,500 | 5,540 | +20 | +0.4% | 2,600 |
| 2017/02/24 | 5,540 | 5,540 | 5,510 | 5,520 | -30 | -0.5% | 1,800 |
| 2017/02/23 | 5,480 | 5,550 | 5,480 | 5,550 | +10 | +0.2% | 3,000 |
| 2017/02/22 | 5,560 | 5,560 | 5,530 | 5,540 | +20 | +0.4% | 1,200 |
| 2017/02/21 | 5,530 | 5,540 | 5,500 | 5,520 | -20 | -0.4% | 2,300 |
| 2017/02/20 | 5,510 | 5,550 | 5,510 | 5,540 | +20 | +0.4% | 900 |
| 2017/02/17 | 5,530 | 5,580 | 5,520 | 5,520 | -30 | -0.5% | 1,500 |
| 2017/02/16 | 5,560 | 5,580 | 5,540 | 5,550 | -20 | -0.4% | 800 |
1851～
1900
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「日ケミファ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日ケミファ | 151,100円 | +2.5% | - | 3.31% | 90.86倍 | 0.29倍 |
|
中堅後発薬メーカー。長期収載品の主力は痛風薬ウラリット。新薬開発、検査薬事業を中期強化 |
| ティムス | 20,500円 | - | - | 0.00% | - | 2.78倍 |
|
東京農工大発創薬ベンチャー。黒カビ由来の急性期脳梗塞薬候補品を香港拠点ジーシンに導出 |
| ノイルイミューン | 17,300円 | -97.8% | - | 0.00% | - | 1.50倍 |
|
独自技術用いたＣＡＲ－Ｔ細胞免疫療法で抗がん剤を複数開発中。中外製薬とライセンス契約 |
| カルナバイオ | 31,000円 | -43.1% | - | 0.00% | - | 1.84倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
| ＶＩＳ | 89,000円 | +87.8% | +265.7% | 0.00% | 53.45倍 | 2.45倍 |
|
ｍＲＮＡ標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
市場注目の銘柄
チャート関連のコラム
